Early detection and integrated care for adolescents and young adults with psychotic disorders: the ACCESS III study

Acta Psychiatrica Scandinavica

Volumn 136, Issue 2, 2017, Pages 188-200

  Lambert, M ^a   Schottle D ^a   Ruppelt, F ^a   Rohenkohl, A ^a   Sengutta, M ^a   Luedecke, D ^a   Nawara, L A ^a   Galling, B ^b   Falk, A L ^a   Wittmann, L ^a   Niehaus, V ^a   Sarikaya, G ^a   Rietschel, L ^c   Gagern, C ^d   Schulte Markwort, M ^a   Unger, H P ^e   Ott, S ^e   Romer, G ^f   Daubmann, A ^a   Wegscheider, K ^a   Correll, C U ^b   Schimmelmann, B G ^a,c   Wiedemann, K ^a   Bock, T ^a   Gallinat, J ^a   Karow, A ^a   more..

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b ZUCKER HILLSIDE HOSPITAL   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

^d UNIVERSITY OF HAMBURG   (Germany)

^e Asklepios Klinik Harburg   (Germany)

^f UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

bipolar disorder; early detection; early psychosis; integrated care; schizophrenia

Indexed keywords

ADOLESCENT; ADULT; AFFECTIVE PSYCHOSIS; AGE; ARTICLE; BIPOLAR I DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELUSIONAL DISORDER; DISEASE DURATION; DRUG DEPENDENCE; EARLY DETECTION AND INTEGRATED CARE; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HUMAN; INTEGRATED HEALTH CARE SYSTEM; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MENTAL HEALTH CARE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOSIS; QUALITY OF LIFE; REMISSION; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIA SPECTRUM DISORDER; SCHIZOPHRENIFORM DISORDER; SUICIDE ATTEMPT; DIET THERAPY; EARLY INTERVENTION; PATIENT CARE; PROSPECTIVE STUDY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; EARLY DIAGNOSIS; EARLY MEDICAL INTERVENTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LINEAR MODELS; PATIENT CARE; PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS; YOUNG ADULT;

EID: 85020234575     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12762     Document Type: Article

References (64)

1. Lambert M, Schottle D, Sengutta M et al. Early detection and integrated care for adolescents and young adults with severe psychotic disorders: rationales and design of the Integrated Care in Early Psychosis Study (ACCESS III). Early Interv Psychiatry 2016. https://doi.org/10.1111/eip.12361. [Epub ahead of print]
2. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry 2005;62:975–983.
3. Boonstra N, Klaassen R, Sytema S et al. Duration of untreated psychosis and negative symptoms–a systematic review and meta-analysis of individual patient data. Schizophr Res 2012;142:12–19.
4. Penttila M, Jaaskelainen E, Hirvonen N, Isohanni M, Miettunen J. Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis. Br J Psychiatry 2014;205:88–94.
5. Cotter J, Zabel E, French P, Yung AR. Prolonged duration of untreated psychosis: a problem that needs addressing. Early Interv Psychiatry 2017;11:263–268.
6. Cechnicki A, Cichocki L, Kalisz A, Bladzinski P, Adamczyk P, Franczyk-Glita J. Duration of untreated psychosis (DUP) and the course of schizophrenia in a 20-year follow-up study. Psychiatry Res 2014;219:420–425.
7. Guo X, Zhai J, Liu Z et al. Effect of antipsychotic medication alone vs combined with psychosocial intervention on outcomes of early-stage schizophrenia: a randomized, 1-year study. Arch Gen Psychiatry 2010;67:895–904.
8. Lambert M, Bock T, Schottle D et al. Assertive community treatment as part of integrated care versus standard care: a 12-month trial in patients with first- and multiple-episode schizophrenia spectrum disorders treated with quetiapine immediate release (ACCESS trial). J Clin Psychiatry 2010;71:1313–1323.
9. Schottle D, Schimmelmann BG, Karow A et al. Effectiveness of integrated care including therapeutic assertive community treatment in severe schizophrenia spectrum and bipolar I disorders: the 24-month follow-up ACCESS II study. J Clin Psychiatry 2014;75:1371–1379.
10. Schottle D, Karow A, Schimmelmann BG, Lambert M. Integrated care in patients with schizophrenia: results of trials published between 2011 and 2013 focusing on effectiveness and efficiency. Curr. Opin. Psychiatry 2013 Jul;26:384–408.
11. Kane JM, Robinson DG, Schooler NR et al. Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program. Am J Psychiatry 2016;173:362–372.
12. Joa I, Johannessen JO, Auestad B et al. The key to reducing duration of untreated first psychosis: information campaigns. Schizophr Bull 2008 May;34:466–472.
13. Lloyd-Evans B, Crosby M, Stockton S et al. Initiatives to shorten duration of untreated psychosis: systematic review. Br J Psychiatry 2011;198:256–263.
14. Nordentoft M, Thorup A, Petersen L et al. Does a detection team shorten duration of untreated psychosis? Early Interv Psychiatry 2008;2:22–26.
15. Lloyd-Evans B, Sweeney A, Hinton M et al. Evaluation of a community awareness programme to reduce delays in referrals to early intervention services and enhance early detection of psychosis. BMC Psychiatry 2015;15:98.
16. Srihari VH, Tek C, Pollard J et al. Reducing the duration of untreated psychosis and its impact in the U.S.: the STEP-ED study. BMC Psychiatry 2014;14:335.
17. Chan SK, Chau EH, Hui CL, Chang WC, Lee EH, Chen EY. Long term effect of early intervention service on duration of untreated psychosis in youth and adult population in Hong Kong. Early Interv Psychiatry 2016 https://doi.org/10.1111/eip.12313. [Epub ahead of print].
18. Henry LP, Amminger GP, Harris MG et al. The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission. J Clin Psychiatry 2010;71:716–728.
19. McGorry PD, Edwards J, Mihalopoulos C, Harrigan SM, Jackson HJ. EPPIC: an evolving system of early detection and optimal management. Schizophr Bull 1996;22:305–326.
20. Melle I, Larsen TK, Haahr U et al. Reducing the duration of untreated first-episode psychosis: effects on clinical presentation. Arch Gen Psychiatry 2004;61:143–150.
21. Hegelstad WT, Larsen TK, Auestad B et al. Long-term follow-up of the TIPS early detection in psychosis study: effects on 10-year outcome. Am J Psychiatry 2012;169:374–380.
22. Johannessen JO, McGlashan TH, Larsen TK et al. Early detection strategies for untreated first-episode psychosis. Schizophr Res 2001;51:39–46.
23. Jorgensen P, Nordentoft M, Abel MB, Gouliaev G, Jeppesen P, Kassow P. Early detection and assertive community treatment of young psychotics: the Opus Study – Rationale and design of the trial. Soc Psychiatry Psychiatr Epidemiol 2000;35:283–287.
24. Petersen L, Jeppesen P, Thorup A et al. A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness. BMJ 2005;331:602.
25. Briand C, Menear M. Implementing a continuum of evidence-based psychosocial interventions for people with severe mental illness: part 2-review of critical implementation issues. Can J Psychiatry 2014;59:187–195.
26. Delespaul PH, De Consensusgroep EPA. [Consensus regarding the definition of persons with severe mental illness and the number of such persons in the Netherlands]. Tijdschr Psychiatr. 2013;55:427–438.
27. Guhne U, Weinmann S, Arnold K, Becker T, Riedel-Heller SG. S3 guideline on psychosocial therapies in severe mental illness: evidence and recommendations. Eur Arch Psychiatry Clin Neurosci 2015;265:173–188.
28. Menear M, Briand C. Implementing a continuum of evidence-based psychosocial interventions for people with severe mental illness: part 1-review of major initiatives and implementation strategies. Can J Psychiatry 2014;59:178–186.
29. Conus P, Cotton SM, Schimmelmann BG, McGorry PD, Lambert M. The First-Episode Psychosis Outcome Study: premorbid and baseline characteristics of an epidemiological cohort of 661 first-episode psychosis patients. Early Interv Psychiatry 2007;1:191–200.
30. Petersen L, Thorup A, Oqhlenschlaeger J et al. Predictors of remission and recovery in a first-episode schizophrenia spectrum disorder sample: 2-year follow-up of the OPUS trial. Can J Psychiatry 2008;53:660–670.
31. Bertelsen M, Jeppesen P, Petersen L et al. Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness: the OPUS trial. Arch Gen Psychiatry 2008;65:762–771.
32. Secher RG, Hjorthoj CR, Austin SF et al. Ten-year follow-up of the OPUS specialized early intervention trial for patients with a first episode of psychosis. Schizophr Bull 2015;41:617–626.
33. Lambert M, Schottle D, Ruppelt F et al. [Integrated care for patients with first and multiple episodes of severe psychotic illnesses: 3-year results of the Hamburg model]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2015;58:408–419.
34. Harter M, Kentgens M, Brandes A et al. Rationale and content of psychenet: the Hamburg Network for Mental Health. Eur Arch Psychiatry Clin Neurosci 2012;262(Suppl 2):S57–S63.
35. Lambert M, Harter M, Arnold D et al. Improving mental health literacy and mental illness stigma in the population of Hamburg. Psychiatr Prax 2015;42(Suppl 1):S9–S13.
36. AMERICAN PSYCHIATRIC ASSOCIATION DI. American Psychiatric Association and Task Force on DSM IV. Diagnostic and Statistical Manual of Mental Disorders, DSM IV. 4th edn. Washington, DC: APA; 1994.
37. Wittchen H, Zaudig M, Fydrich T. SKID-I und SKID-II: Strukturiertes Klinisches Interview für DSM-IV, Achse I: Psychische Störungen/Achse II: Persönlichkeitsstörungen. Göttingen: Hogrefe; 1997.
38. Dilling H, Mombour W, Schmidt MH, Schulte-Markwort M. Internationale Klassifikation psychischer Störungen: ICD-10 Kapitel V (F) Klinisch-diagnostische Leitlinien. Bern: Huber, Hans; 2004.
39. Dittmann V, Dilling H. Chapter V (F) of ICD-10: mental, behavioural and developmental disorders–introduction and overview. Pharmacopsychiatry 1990;23(Suppl 4):137–141.
40. McGorry PD, Copolov DL, Singh BS. Royal park multidiagnostic instrument for psychosis: part I. Rationale and review. Schizophr Bull 1990;16:501–515.
41. Lambert M, Conus P, Lubman DI et al. The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatr Scand 2005;112:141–148.
42. McGorry PD, Singh BS, Copolov DL, Kaplan I, Dossetor CR, Van Riel RJ. Royal park multidiagnostic instrument for psychosis: part II. Development, reliability, and validity. Schizophr Bull 1990;16:517–536.
43. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261–276.
44. Guy W. Clinical global impression. Rockville, MD: National Institute for Mental Health; 1976.
45. Haro JM, Kamath SA, Ochoa S et al. The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatr Scand Suppl 2003;2003:16–23.
46. Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W. Modification of the clinical global impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 1997;73:159–171.
47. Ritsner M, Kurs R, Gibel A, Ratner Y, Endicott J. Validity of an abbreviated quality of life enjoyment and satisfaction questionnaire (Q-LES-Q-18) for schizophrenia, schizoaffective, and mood disorder patients. Qual Life Res 2005;14:1693–1703.
48. Nguyen TD, Attkisson CC, Stegner BL. Assessment of patient satisfaction: development and refinement of a service evaluation questionnaire. Eval Program Plann. 1983;6:299–313.
49. Green JG, McLaughlin KA, Berglund PA et al. Childhood adversities and adult psychiatric disorders in the national comorbidity survey replication I: associations with first onset of DSM-IV disorders. Arch Gen Psychiatry 2010;67:113–123.
50. Andreasen NC, Carpenter WT Jr, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005;162:441–449.
51. Albert N, Bertelsen M, Thorup A et al. Predictors of recovery from psychosis Analyses of clinical and social factors associated with recovery among patients with first-episode psychosis after 5 years. Schizophr Res 2010;125:257–266.
52. Lambert M, Karow A, Leucht S, Schimmelmann BG, Naber D. Remission in schizophrenia: validity, frequency, predictors, and patients’ perspective 5 years later. Dialogues Clin Neurosci 2010;12:393–407.
53. Addington J, Heinssen RK, Robinson DG et al. Duration of untreated psychosis in community treatment settings in the United States. Psychiatr Serv 2015;66:753–756.
54. Schimmelmann BG, Conus P, Cotton S, McGorry PD, Lambert M. Pre-treatment, baseline, and outcome differences between early-onset and adult-onset psychosis in an epidemiological cohort of 636 first-episode patients. Schizophr Res 2007;95:1–8.
55. Schimmelmann BG, Conus P, Edwards J, McGorry PD, Lambert M. Diagnostic stability 18 months after treatment initiation for first-episode psychosis. J Clin Psychiatry 2005;66:1239–1246.
56. Tohen M, Khalsa HM, Salvatore P et al. The McLean-Harvard first-episode project: early course in 114 cases of first-episode nonaffective psychoses. J Clin Psychiatry 2016;77:781–788.
57. Fusar-Poli P, Cappucciati M, Rutigliano G et al. Diagnostic Stability of ICD/DSM First Episode Psychosis Diagnoses: meta-analysis. Schizophr Bull 2016;42:1395–1406.
58. Robinson DG, Woerner MG, McMeniman M, Mendelowitz A, Bilder RM. Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 2004;161:473–479.
59. Chang WC, Tang JY, Hui CL et al. Prediction of remission and recovery in young people presenting with first-episode psychosis in Hong Kong: a 3-year follow-up study. Aust N Z J Psychiatry 2012;46:100–108.
60. Harvey PD, Bellack AS. Toward a terminology for functional recovery in schizophrenia: is functional remission a viable concept? Schizophr Bull 2009;35:300–306.
61. Clemmensen L, Vernal DL, Steinhausen HC. A systematic review of the long-term outcome of early onset schizophrenia. BMC Psychiatry 2012;12:150.
62. Hatta K. Practical pharmacotherapy for acute schizophrenia patients. Psychiatry Clin Neurosci 2015;69:674–685.
63. First MB, Spitzer RL, Miriam G, Williams JBW. Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition. (SCID-I/P) New York: Biometrics Research, New York State Psychiatric Institute; 2002.
64. Overall J, Gorham D. The brief psychiatric rating scale. Psychol Rep 1962;10:799–812.